The body of research proving the efficacy of “magic mushrooms” to ameliorate various mental ailments continues to grow. Read More

Legislation to provide marijuana companies freer access to financial services is seeing renewed life in Congress. Read More

Pot stocks have endured a bumpy ride this year, but cannabis investments are laying the groundwork for upward trajectory next year. Read More

We’re quickly approaching a time when artificial intelligence will be fully incorporated into a myriad of marijuana-related functions. Read More

California lawmakers have passed a psychedelics decriminalization bill and Governor Gavin Newsom will probably sign it. The money race is on. Read More

A new report reveals a dichotomy in choices between those who are veteran purchasers of cannabis, and the newbies to the market. Read More

Psychedelics once demonized by polite society are now being deployed by the government and medical establishment to combat tobacco addiction. Read More

Health and Human Services announced this week that it’s asking the Drug Enforcement Administration to move cannabis from Schedule I to Schedule III. Read More

Instead of the multi-billion-dollar deals that grabbed headlines in the past, we’ll see a slew of smaller transactions in coming months. Read More

Consumption rates among Americans of marijuana and hallucinogenic substances are at historic levels. Investors are taking notice. Read More